BSC
CRL icon

BOLTON SECURITIES CORPORATION’s Charles River Laboratories CRL Stock Holding History

BOLTON SECURITIES CORPORATION’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18.1K Buy
+105
New +$19.5K ﹤0.01% 1487
2025
Q3 		$16.4K Buy
+105
New +$16.7K ﹤0.01% 1435
2025
Q1 		$78.7K Buy
+523
New +$87.7K ﹤0.01% 936

Other funds holding CRL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BOLTON SECURITIES CORPORATION's CRL Position: Q1 2026 in Review

BOLTON SECURITIES CORPORATION opened a new position in Charles River Laboratories (CRL) in Q1 2026: 105 shares worth $18.1K. The stake represents ﹤0.01% of the portfolio and ranks #1487 among its holdings. This is a return to the name: BOLTON SECURITIES CORPORATION previously reported a position in CRL as recently as Q3 2025.

BOLTON SECURITIES CORPORATION first reported a position in CRL in Q1 2025 and has held it in 3 quarters since. The position peaked at $78.7K in Q1 2025. 562 funds tracked by Wall St. Rank hold CRL as of Q1 2026.

  • BOLTON SECURITIES CORPORATION held 105 shares of Charles River Laboratories worth $18.1K as of Q1 2026.
  • Charles River Laboratories was a new BOLTON SECURITIES CORPORATION position in Q1 2026.
  • Charles River Laboratories made up ﹤0.01% of BOLTON SECURITIES CORPORATION's portfolio in Q1 2026, its #1487 holding.
  • BOLTON SECURITIES CORPORATION first reported a position in Charles River Laboratories in Q1 2025 and has held it in 3 quarters since.
  • BOLTON SECURITIES CORPORATION's Charles River Laboratories position peaked at $78.7K in Q1 2025.
  • 562 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.

Based on BOLTON SECURITIES CORPORATION's 13F filing for Q1 2026, filed 12 Nov 2026.